中国医学创新
中國醫學創新
중국의학창신
Medical Innovation of China
2015年
28期
106-109
,共4页
周华姣%岳红%王明喜%徐朝霞
週華姣%嶽紅%王明喜%徐朝霞
주화교%악홍%왕명희%서조하
剖宫产术后%催产素引产%瘢痕子宫
剖宮產術後%催產素引產%瘢痕子宮
부궁산술후%최산소인산%반흔자궁
Cesarean section%Oxytocin%Uterine scar
目的:研究探讨催产素是否能应用于剖宫产术后足月妊娠的引产。方法:收集自2012年2月-2014年3月于本院就诊并住院分娩的剖宫产后再次妊娠孕妇842例,观察催产素引产的临床应用效果,分析其安全性。结果:瘢痕子宫组孕妇接受催产素引产治疗,发生产后出血3例,发生率为6.52%,无产褥感染情况,无新生儿转入NICU,住院时间2~9 d,平均(4.24±2.05)d,与非瘢痕子宫组比较差异均无统计学意义(P<0.05)。结论:催产素在剖宫产术后足月妊娠引产是可行且相对安全的。
目的:研究探討催產素是否能應用于剖宮產術後足月妊娠的引產。方法:收集自2012年2月-2014年3月于本院就診併住院分娩的剖宮產後再次妊娠孕婦842例,觀察催產素引產的臨床應用效果,分析其安全性。結果:瘢痕子宮組孕婦接受催產素引產治療,髮生產後齣血3例,髮生率為6.52%,無產褥感染情況,無新生兒轉入NICU,住院時間2~9 d,平均(4.24±2.05)d,與非瘢痕子宮組比較差異均無統計學意義(P<0.05)。結論:催產素在剖宮產術後足月妊娠引產是可行且相對安全的。
목적:연구탐토최산소시부능응용우부궁산술후족월임신적인산。방법:수집자2012년2월-2014년3월우본원취진병주원분면적부궁산후재차임신잉부842례,관찰최산소인산적림상응용효과,분석기안전성。결과:반흔자궁조잉부접수최산소인산치료,발생산후출혈3례,발생솔위6.52%,무산욕감염정황,무신생인전입NICU,주원시간2~9 d,평균(4.24±2.05)d,여비반흔자궁조비교차이균무통계학의의(P<0.05)。결론:최산소재부궁산술후족월임신인산시가행차상대안전적。
Objective:To discuss whether oxytocin can be applied to full-term pregnancy induced labor after cesarean. Method:842 pregnant women after cesarean section and again pregnancy were collected from February 2012 to March 2014 in our hospital,the clinical effect of oxytocin was observed,its security was analyzed. Result:The uterine scar group accepted oxytocin treatment,its postpartum hemorrhage occurred in 3 cases,the rate was 6.52%,non-puerperal infection,no newborns was transferred to NICU,hospital stay were 2 to 9 days,the average were (4.24±2.05)days,compared with non-uterine scar group,the difference was no statistically significant(P<0.05). Conclusion:Oxytocin induction of labor at term of pregnancy after cesarean are feasible and relatively safe.